---
title: Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
date: '2024-06-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38828946
source: Trending page - PubMed
description: <span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Lu+S&amp;cauthor_id=38828946"
  ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link"
  data-ga-label="Shun Lu">Shun Lu</a><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span><a
  class="affiliation-link" title="From the Department of Medical Oncology, Shanghai
  Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai (S.L.),
  the Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of
  Science and ...
disable_comments: true
---
<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Lu+S&amp;cauthor_id=38828946" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="Shun Lu">Shun Lu</a><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="From the Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai (S.L.), the Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and ...